Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.
2.

Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones.

Meller E, Bohmaker K.

J Pharmacol Exp Ther. 1994 Dec;271(3):1246-52.

PMID:
7996433
3.

Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors.

Meller E, Bohmaker K, Goldstein M, Basham DA.

Eur J Pharmacol. 1993 Nov 2;249(1):R5-6.

PMID:
7904244
4.

Extracellular dopamine concentration in the retina of the clawed frog, Xenopus laevis.

Witkovsky P, Nicholson C, Rice ME, Bohmaker K, Meller E.

Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5667-71.

5.
6.

A novel method for rapid enrichment of lactotrophs from dispersed anterior pituitary cells of the rat.

Meller E, Bohmaker K, Puza T, Diamond J, Lew JY, Schütte M, Okrongly D, Goldstein M.

Neuroendocrinology. 1993 Jun;57(6):1042-7.

PMID:
7901782
7.

Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.

Meller E, Puza T, Diamond J, Lieu HD, Bohmaker K.

J Pharmacol Exp Ther. 1992 Nov;263(2):462-9.

PMID:
1359107
8.

Serotonin 5-HT1A receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance.

Meller E, Chalfin M, Bohmaker K.

Pharmacol Biochem Behav. 1992 Oct;43(2):405-11.

PMID:
1359573
11.

Involvement of D1 and D2 Dopamine Receptors in the Control of Horizontal Cell Electrical Coupling in the Turtle Retina.

Piccolino M, Demontis G, Witkovsky P, Strettoi E, Cappagli GC, Porceddu ML, De Montis MG, Pepitoni S, Biggio G, Meller E, Bohmaker K.

Eur J Neurosci. 1989 May;1(3):247-257.

PMID:
12106155
12.

Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.

Meller E, Bordi F, Bohmaker K.

Life Sci. 1989;44(15):1019-26.

PMID:
2564615
13.

Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.

Bohmaker K, Puza T, Goldstein M, Meller E.

J Pharmacol Exp Ther. 1989 Jan;248(1):97-103.

PMID:
2563295
15.

Relationship between receptor occupancy and response at striatal dopamine autoreceptors.

Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M.

Mol Pharmacol. 1987 Jun;31(6):592-8.

PMID:
2885734
16.

Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists.

Meller E, Helmer-Matyjek E, Bohmaker K, Adler CH, Friedhoff AJ, Goldstein M.

Eur J Pharmacol. 1986 Apr 16;123(2):311-4.

PMID:
3709668
17.

Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.

Meller E, Bohmaker K, Goldstein M, Friedhoff AJ.

J Pharmacol Exp Ther. 1985 Jun;233(3):656-62.

PMID:
2861276
18.

Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.

Meller E, Bohmaker K, Goldstein M, Schweitzer JW, Friedhoff AJ.

Eur J Pharmacol. 1985 Mar 12;109(3):389-94.

PMID:
3157587
19.

Differential effects of chronic clorgyline and amfonelic acid on desensitization of striatal dopamine receptors.

Meller E, Bohmaker K, Friedhoff AJ.

Life Sci. 1984 Oct 29;35(18):1829-38.

PMID:
6492992
20.

Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.

Meller E, Bohmaker K, Rosengarten H, Friedhoff AJ.

Res Commun Chem Pathol Pharmacol. 1982 Sep;37(3):323-32.

PMID:
7178646

Supplemental Content

Loading ...
Support Center